MedTrace Logo

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

NCT00897143 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-10-09

No results posted yet for this study

Summary

RATIONALE: Studying samples of pleural fluid in the laboratory from patients with lung cancer may help doctors identify early lung cancer cells. It may also help the study of lung cancer in the future.

PURPOSE: This laboratory study is looking at malignant pleural effusion samples from patients with primary lung cancer to see if early lung cancer cells can be identified.

Conditions

Interventions

GENETIC

microarray analysis

analyzed using an immunomagnetic bead enrichment assay to isolate cells of epithelial origin

GENETIC

mutation analysis

analyzed using an immunomagnetic bead enrichment assay to isolate cells of epithelial origin

OTHER

flow cytometry

analyzed using an immunomagnetic bead enrichment assay to isolate cells of epithelial origin

OTHER

immunologic technique

analyzed using an immunomagnetic bead enrichment assay to isolate cells of epithelial origin

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Balazs Halmos, MD · Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897143 on ClinicalTrials.gov